Cargando…
SAT277 Intracellular Cortisol Control: An Approach To Reduce Cushing’s Syndrome Morbidity With Minimal Adrenal Insufficiency Risk?
Disclosure: F.S. Czerwiec: Employee; Self; Sparrow Pharmaceuticals, Inc. Stock Owner; Self; Sparrow Pharmaceuticals, Inc. D.A. Katz: Employee; Self; Sparrow Pharmaceuticals, Inc. Stock Owner; Self; Sparrow Pharmaceuticals, Inc. P.M. Stewart: Advisory Board Member; Self; Sparrow Pharmaceuticals, Inc....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553481/ http://dx.doi.org/10.1210/jendso/bvad114.282 |